Skip to content

NAD+ Precursors (NMN/NR)

Precursors to NAD+, a critical coenzyme for cellular energy and longevity pathways. NAD+ levels decline with age.

ModerateWell-Studied Beginner-Friendly

Always consult a qualified clinician

This information is for educational purposes. Peptide therapy should be guided by a licensed healthcare provider. Connect with a Noho clinician

What is NAD+ Precursors (NMN/NR)?

NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside) are precursors to NAD+ (nicotinamide adenine dinucleotide), a coenzyme essential for cellular energy production, DNA repair, and sirtuin activation. NAD+ levels decline 50% between ages 40-60. Supplementation aims to restore youthful NAD+ levels and support longevity pathways. While not technically peptides, they are commonly discussed alongside peptides in the longevity community.

Why People Talk About It

Restoring age-related NAD+ decline

Moderate

Sirtuin activation for longevity

Emerging

Cellular energy and mitochondrial function

Moderate

DNA repair support

Emerging

How It Works

NAD+ is the fuel your cells need for energy production and repair. Levels drop as you age. NMN and NR are building blocks that your body converts into NAD+, potentially restoring more youthful cellular function.

Common Questions

Safety Information

Important Safety Notes

Common Side Effects

Generally well-toleratedMild GI discomfort at high dosesFlushing (less than niacin)

Cautions

  • Long-term effects of supraphysiological NAD+ levels unknown
  • Theoretical concern about fueling cancer cell metabolism
  • Quality varies between supplement brands

What We Don't Know

Whether raising NAD+ levels translates to meaningful lifespan extension in humans is unproven. Long-term safety of chronic supplementation needs more study.

Published Research

21 studies

The Science Behind NMN–A Stable, Reliable NAD+Activator and Anti-Aging Molecule

ReviewPMID: 32549859

NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health

ReviewPMID: 37273100

The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update

ReviewPMID: 37619764

The role of NAD and NAD precursors on longevity and lifespan modulation in the budding yeast, Saccharomyces cerevisiae

PreclinicalPMID: 35260986

Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women

Clinical TrialPMID: 33888596

Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study

Clinical TrialPMID: 34238308

Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects

Clinical TrialPMID: 35479740

The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial

Clinical TrialPMID: 36482258

Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial

Clinical TrialPMID: 36797393

Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men

Clinical TrialPMID: 38191197

Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men

Clinical TrialPMID: 31685720

NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease

Clinical TrialPMID: 38016950

A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment

Clinical TrialPMID: 37994989

Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial

Clinical TrialPMID: 38871717

Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled Trial

Clinical TrialPMID: 40459998

Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin

Clinical TrialPMID: 36515353

Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials

Meta-AnalysisPMID: 39531138

NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence

Systematic ReviewPMID: 41655607

What is really known about the effects of nicotinamide riboside supplementation in humans

ReviewPMID: 37478182

The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans

Clinical TrialPMID: 41540253

Implications of altered NAD metabolism in metabolic disorders

ReviewPMID: 31078136

Always consult a qualified clinician

This information is for educational purposes. Peptide therapy should be guided by a licensed healthcare provider. Connect with a Noho clinician

Related Peptides

Quick Facts

Class
Nucleotide/Vitamin B3 Derivative
Evidence
Moderate
Safety
Well-Studied
Updated
Mar 2026
Citations
21PubMed

Also known as

NMNNRNicotinamide MononucleotideNicotinamide RibosideTru NiagenBasis

Tags

LongevityAnti-AgingCellular EnergySirtuin Activation

Evidence Score

Overall Confidence62%

Clinical Trials

View Clinical Trials

Links to ClinicalTrials.gov for reference. Listing does not imply endorsement.

Clinician Guided

Interested in this peptide? A Noho clinician can help determine if it's right for you.

Talk to a Clinician